Skip to content

Novel techniques probed in cure research

Photo: International AIDS Society/Steve Forrest

High levels of adherence to study medication among women who conceived during HIV PrEP study

High rates of drug resistance among HIV-positive infants in South Africa

Therapy with newer, safer antiretrovirals an option for the majority of HIV-positive patients

Protease inhibitor therapy increases underlying genetic risk of diabetes for women with HIV

PrEP users say it provides an 'extra layer of protection' and 'peace of mind'

People starting therapy on a boosted protease inhibitor don't need to switch after one virological failure episode, study indicates

Study shows prognostic value of viral load monitoring among people living with subtype C HIV in South Africa

Low vitamin D concentrations associated with poor clinical and virological outcomes among people starting HIV therapy